Conference call and webcast to be held at 4:30p.m. ET Conference call and webcast to be held at 4:30p.m. ET
Read more from the original source:
Travere Therapeutics Provides Regulatory Update on Sparsentan Development Program for Focal Segmental Glomerulosclerosis
Recommendation and review posted by Fredricko
